Relebactam Monohydrate

Preferred Label : Relebactam Monohydrate;

NCIt related terms : RELEBACTAM;

NCIt definition : The monohydrate form of relebactam, a beta-lactamase inhibitor, that can be used to inhibit the breakdown of certain drugs, such as the broad spectrum beta-lactam carbapenem antibiotic imipenem. Upon administration of relebactam monohydrate, relebactam targets, binds to and inhibits beta-lactamase. This reduces the breakdown of drugs, such as imipenem, and thereby increases the activity and therapeutic effect of such drugs that would otherwise be inactivated by beta-lactamase.;

UNII : Y1MYA2UHFL;

InChIKey : TWFRCSHLWKJBQH-UXQCFNEQSA-N;

CAS number : 1174020-13-3;

NCI Metathesaurus CUI : CL553508;

Details

Origin ID

C152176;

UMLS CUI

C4726670;

Automatic exact mappings (from CISMeF team)
- Relebactam (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Relebactam monohydrate [SMS substance]
- Relebactam monohydrate (substance) [SNOMED CT concept]
Semantic type(s)
- Antibiotic [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Relebactam monohydrate (substance) [SNOMED CT concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients